In conclusion, we demonstrated that the DHIVAx assay, which includes a combination of polypeptide antigens (gp41e, p31, p17, and Nef), enables the detection of HIV infection with promising specificity and sensitivity, early after infection and without VISR induced by the mosaic-based HIV-1 vaccine regimen. The gene discussed is S100B; the disease is infection.